Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 Mar;15(3):455–460. doi: 10.1128/aac.15.3.455

Role of Vancomycin as a Component of Oral Nonabsorbable Antibiotics for Microbial Suppression in Leukemic Patients

John F Bender 1, Stephen C Schimpff 1, Viola Mae Young 1, Clarence L Fortner 1, Mary D Brouillet 1, Lillian J Love 1, Peter H Wiernik 1
PMCID: PMC352683  PMID: 464573

Abstract

A total of 38 adult patients with acute leukemia who were undergoing remission induction chemotherapy in regular patient rooms were randomly allocated to one of two oral nonabsorbable antibiotic regimens for infection prophylaxis (gentamicin, vancomycin, and nystatin [GVN] or gentamicin and nystatin [GN]) to evaluate whether vancomycin was a necessary component. The patient population in both groups were comparable. Tolerance to GVN was less than GN but compliance was approximately equal (>85% in both groups). Patients receiving vancomycin demonstrated greater overall alimentary tract microbial suppression; however, acquisition of potential pathogens was approximately equal in both groups. The incidence of bacteremia, as well as the overall incidence of infection as related to the number of days at various granulocyte levels, was also approximately equal in both groups. Group D Streptococcus species were poorly suppressed by GN compared with GVN, although no patient developed an infection with these organisms. Colonization by newly acquired gram-negative bacilli was significantly less in the GN group (GN, 3 colonizations; GVN, 13 colonizations; P < 0.01). It is concluded that vancomycin may be safely eliminated from the GVN regimen provided microbiological data is monitored to detect resistant organisms.

Full text

PDF
455

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  2. Bodey G. P. Oral antibiotic prophylaxis in protected environment units: effect of nonabsorbable and absorbable antibiotics on the fecal flora. Antimicrob Agents Chemother. 1972 Apr;1(4):343–347. doi: 10.1128/aac.1.4.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bodey G. P., Rodriguez V. Infections in cancer patients on a protected environment-prophylactic antibiotic program. Am J Med. 1975 Oct;59(4):497–504. doi: 10.1016/0002-9343(75)90257-0. [DOI] [PubMed] [Google Scholar]
  4. Hahn D. M., Schimpff S. C., Fortner C. L., Smyth A. C., Young V. M., Wiernik P. H. Infection in acute leukemia patients receiving oral nonabsorable antibiotics. Antimicrob Agents Chemother. 1978 Jun;13(6):958–964. doi: 10.1128/aac.13.6.958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Keating M. J., Penington D. G. Prophylaxis against septicaemia in acute leukaemia: the use of oral framycetin. Med J Aust. 1973 Aug 4;2(5):213–217. [PubMed] [Google Scholar]
  6. Levi J. A., Vincent P. C., Jennis F., Lind D. E., Gunz F. W. Prophylactic oral antibiotics in the management of acute leukaemia. Med J Aust. 1973 May 26;1(21):1025–1029. [PubMed] [Google Scholar]
  7. Levine A. S., Schimpff S. C., Graw R. G., Jr, Young R. C. Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol. 1974 Apr;11(2):141–202. [PubMed] [Google Scholar]
  8. Levine A. S., Siegel S. E., Schreiber A. D., Hauser J., Preisler H., Goldstein I. M., Seidler F., Simon R., Perry S., Bennett J. E. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med. 1973 Mar 8;288(10):477–483. doi: 10.1056/NEJM197303082881001. [DOI] [PubMed] [Google Scholar]
  9. MacLowry J. D., Jaqua M. J., Selepak S. T. Detailed methodology and implementation of a semiautomated serial dilution microtechnique for antimicrobial susceptibility testing. Appl Microbiol. 1970 Jul;20(1):46–53. doi: 10.1128/am.20.1.46-53.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Preisler H. D., Goldstein I. M., Henderson E. S. Gastrointestinal "sterilization" in the treatment of patients with acute leukemia. Cancer. 1970 Nov;26(5):1076–1081. doi: 10.1002/1097-0142(197011)26:5<1076::aid-cncr2820260516>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  11. Schimpff S. C., Greene W. H., Young V. M., Fortner C. L., Cusack N., Block J. B., Wiernik P. H. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med. 1975 Mar;82(3):351–358. doi: 10.7326/0003-4819-82-3-351. [DOI] [PubMed] [Google Scholar]
  12. Schimpff S. C. Therapy of infection in patients with granulocytopenia. Med Clin North Am. 1977 Sep;61(5):1101–1118. doi: 10.1016/s0025-7125(16)31284-6. [DOI] [PubMed] [Google Scholar]
  13. Schimpff S. C., Young V. M., Greene W. H., Vermeulen G. D., Moody M. R., Wiernik P. H. Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med. 1972 Nov;77(5):707–714. doi: 10.7326/0003-4819-77-5-707. [DOI] [PubMed] [Google Scholar]
  14. Storring R. A., Jameson B., McElwain T. J., Wiltshaw E. Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet. 1977 Oct 22;2(8043):837–840. doi: 10.1016/s0140-6736(77)90779-6. [DOI] [PubMed] [Google Scholar]
  15. Yates J. W., Holland J. F. A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer. 1973 Dec;32(6):1490–1498. doi: 10.1002/1097-0142(197312)32:6<1490::aid-cncr2820320628>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  16. van der Waaij D., Berghuis-de Vries J. M., Lekkerkerk Lekkerkerk-v Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) 1971 Sep;69(3):405–411. doi: 10.1017/s0022172400021653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. van der Waaij D., Berghuis-de Vries J. M. Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys. J Hyg (Lond) 1974 Apr;72(2):205–211. doi: 10.1017/s002217240002341x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES